InvestorsHub Logo
Followers 17
Posts 878
Boards Moderated 0
Alias Born 02/14/2020

Re: Ecomike post# 27922

Sunday, 10/18/2020 6:12:12 AM

Sunday, October 18, 2020 6:12:12 AM

Post# of 44284
For the OTC, 300 mil is low. They will not need to R/S to uplist. The Priority Review Voucher for the symptomatic rabies treatment is alone worth $125-200 million, now couple that with the new patent they just acquired and whatever other irons they have in the fire, a $300 million market cap will not be hard to achieve for this company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CUBT News